Literature DB >> 7568199

Glutamate as a hippocampal neuron survival factor: an inherited defect in the trisomy 16 mouse.

L L Bambrick1, P J Yarowsky, B K Krueger.   

Abstract

The survival of cultured mouse hippocampal neurons was found to be greatly enhanced by micromolar concentrations of the excitatory neurotransmitter glutamate. Blockade of kainate/AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) glutamate receptors increased the rate of neuron death, suggesting that endogenous glutamate in the cultures promotes survival. Addition of glutamate (0.5-1 microM) further increased neuron survival, whereas glutamate in excess of 20 microM resulted in increased death. Thus, the survival vs. glutamate dose-response relation is bell-shaped with an optimal glutamate concentration near 1 microM. We found that hippocampal neurons from mice with the genetic defect trisomy 16 (Ts16) died 2-3 times faster than normal (euploid) neurons. Moreover, glutamate, at all concentrations tested, failed to increase survival of Ts16 neurons. In contrast, the neurotrophic polypeptide basic fibroblast growth factor did increase the survival of Ts16 and euploid neurons. Ts16 is a naturally occurring mouse genetic abnormality, the human analog of which (Down syndrome) leads to altered brain development and Alzheimer disease. These results demonstrate that the Ts16 genotype confers a defect in the glutamate-mediated survival response of hippocampal neurons and that this defect can contribute to their accelerated death.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568199      PMCID: PMC40868          DOI: 10.1073/pnas.92.21.9692

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Activation of metabotropic glutamate receptors prevents neuronal apoptosis in culture.

Authors:  A Copani; V M Bruno; V Barresi; G Battaglia; D F Condorelli; F Nicoletti
Journal:  J Neurochem       Date:  1995-01       Impact factor: 5.372

2.  Depolarization or glutamate receptor activation blocks apoptotic cell death of cultured cerebellar granule neurons.

Authors:  G M Yan; B Ni; M Weller; K A Wood; S M Paul
Journal:  Brain Res       Date:  1994-09-05       Impact factor: 3.252

Review 3.  Programmed cell death and the control of cell survival: lessons from the nervous system.

Authors:  M C Raff; B A Barres; J F Burne; H S Coles; Y Ishizaki; M D Jacobson
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

4.  Morphologic and neurochemical studies of embryonic brain development in murine trisomy 16.

Authors:  H S Singer; M Tiemeyer; J C Hedreen; J Gearhart; J T Coyle
Journal:  Brain Res       Date:  1984-08       Impact factor: 3.252

5.  Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger RNA in response to kainate-induced excitation.

Authors:  C Humpel; B Hoffer; I Strömberg; S Bektesh; F Collins; L Olson
Journal:  Neuroscience       Date:  1994-04       Impact factor: 3.590

6.  Glutamate-mediated astrocyte-neuron signalling.

Authors:  V Parpura; T A Basarsky; F Liu; K Jeftinija; S Jeftinija; P G Haydon
Journal:  Nature       Date:  1994-06-30       Impact factor: 49.962

7.  Blockade of NMDA receptors increases cell death and birth in the developing rat dentate gyrus.

Authors:  E Gould; H A Cameron; B S McEwen
Journal:  J Comp Neurol       Date:  1994-02-22       Impact factor: 3.215

8.  Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination.

Authors:  G J Brewer; J R Torricelli; E K Evege; P J Price
Journal:  J Neurosci Res       Date:  1993-08-01       Impact factor: 4.164

9.  Effects of in vivo administration of kainic acid on the extracellular amino acid pool in the rabbit hippocampus.

Authors:  A Lehmann; H Isacsson; A Hamberger
Journal:  J Neurochem       Date:  1983-05       Impact factor: 5.372

Review 10.  Neurotrophic factors: from molecule to man.

Authors:  R M Lindsay; S J Wiegand; C A Altar; P S DiStefano
Journal:  Trends Neurosci       Date:  1994-05       Impact factor: 13.837

View more
  16 in total

Review 1.  Neurotrophic effects of AMPA.

Authors:  Cristina Limatola
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

2.  Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability.

Authors:  Francesc X Soriano; Sofia Papadia; Frank Hofmann; Neil R Hardingham; Hilmar Bading; Giles E Hardingham
Journal:  J Neurosci       Date:  2006-04-26       Impact factor: 6.167

3.  An L-type calcium channel agonist, bay K8644, extends the window of intervention against ischemic neuronal injury.

Authors:  Hong-hai Hu; Shu-ji Li; Pu Wang; Hua-cheng Yan; Xiong Cao; Feng-qin Hou; Ying-ying Fang; Xin-hong Zhu; Tian-ming Gao
Journal:  Mol Neurobiol       Date:  2012-10-10       Impact factor: 5.590

4.  Altered Ca2+ signaling and mitochondrial deficiencies in hippocampal neurons of trisomy 16 mice: a model of Down's syndrome.

Authors:  S Schuchmann; W Müller; U Heinemann
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

5.  Role of founder cell deficit and delayed neuronogenesis in microencephaly of the trisomy 16 mouse.

Authors:  T F Haydar; R S Nowakowski; P J Yarowsky; B K Krueger
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

6.  Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with glutamate receptor antagonists MK-801 and CPP.

Authors:  A Emmi; H Rajabi; J Stewart
Journal:  J Neurosci       Date:  1996-08-15       Impact factor: 6.167

7.  Failure of brain-derived neurotrophic factor-dependent neuron survival in mouse trisomy 16.

Authors:  Susan G Dorsey; Linda L Bambrick; Rita J Balice-Gordon; Bruce K Krueger
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

8.  Consequences of trisomy 16 for mouse brain development: corticogenesis in a model of Down syndrome.

Authors:  T F Haydar; M E Blue; M E Molliver; B K Krueger; P J Yarowsky
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

Review 9.  Riluzole in the treatment of mood and anxiety disorders.

Authors:  Christopher Pittenger; Vladimir Coric; Mounira Banasr; Michael Bloch; John H Krystal; Gerard Sanacora
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 10.  Glutamate antagonists are neurotoxins for the developing brain.

Authors:  Angela M Kaindl; Chrysanthy Ikonomidou
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.